JKN23041吸入溶液治疗中、重度慢性阻塞性肺疾病(COPD)患者的安全性、有效性的随机、开放、阳性对照IIa期临床研究
[Translation] A randomized, open-label, positive-controlled phase IIa clinical study on the safety and efficacy of JKN23041 inhalation solution in the treatment of patients with moderate to severe chronic obstructive pulmonary disease (COPD)
主要目的:评价不同给药频次下的JKN23041吸入溶液在COPD患者中的安全性;
次要目的:1)评价不同给药频次下的JKN23041吸入溶液在COPD患者中的有效性;2)评价JKN23041吸入溶液在COPD患者中的药代动力学特征。
[Translation] Primary Objective: To evaluate the safety of JKN23041 inhalation solution at different dosing frequencies in patients with COPD.
Secondary Objectives: 1) To evaluate the efficacy of JKN23041 inhalation solution at different dosing frequencies in patients with COPD; 2) To evaluate the pharmacokinetic characteristics of JKN23041 inhalation solution in patients with COPD.
100 Clinical Results associated with
0 Patents (Medical) associated with
100 Deals associated with
100 Translational Medicine associated with